Chk1/ 2 inhibition enhances response to lurbinectedin treatment in small cell lung cancer

被引：1
|
作者：
Uruchurtu, Ashley Sanchez Sevilla
Roady, Tyler
Anderson, Agenxnie
El-Deiry, Wafik S.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3191
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3191
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Inhibition of Chk1 with Prexasertib Enhances the Anticancer Activity of Ciclopirox in Non-Small Cell Lung Cancer Cells
    Huang, Zhu
    Li, Wenjing
    Wu, Yan
    Cheng, Bing
    Huang, Shile
    CELLS, 2024, 13 (21)
  • [2] Chk1 Inhibition Enhances Cisplatin Cytotoxicity Regardless of p53 Status in Human Small Cell Lung Cancer Cells
    Hsu, Wei-Hsun
    Hsu, Shuo-Tse
    Rao, Guanhua
    Kim, In-Gyu
    Alberobello, Anna T.
    Wang, Yisong
    Giaccone, Giuseppe
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S399 - S399
  • [3] Lurbinectedin for the treatment of small cell lung cancer
    Li, L.
    Zou, C.
    Dong, S.
    Wu, Z-X
    Ashby, C. R., Jr.
    Chen, Z-S
    Qiu, C.
    DRUGS OF TODAY, 2021, 57 (06) : 377 - 385
  • [4] CHK1 levels correlate with sensitization to pemetrexed by CHK1 inhibitors in non-small cell lung cancer cells
    Grabauskiene, Svetlana
    Bergeron, Edward J.
    Chen, Guoan
    Chang, Andrew C.
    Lin, Jules
    Thomas, Dafydd G.
    Giordano, Thomas J.
    Beer, David G.
    Morgan, Meredith A.
    Reddy, Rishindra M.
    LUNG CANCER, 2013, 82 (03) : 477 - 484
  • [5] Lurbinectedin in the treatment of relapsed small cell lung cancer
    Baena, Javier
    Modrego, Andrea
    Zeaiter, Ali
    Kahatt, Carmen
    Alfaro, Vicente
    Jimenez-Aguilar, Elizabeth
    Mazarico, Jose Maria
    Paz-Ares, Luis
    FUTURE ONCOLOGY, 2021, 17 (18) : 2279 - 2289
  • [6] Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer
    Doerr, Fabian
    George, Julie
    Schmitt, Anna
    Beleggia, Filippo
    Rehkaemper, Tim
    Hermann, Sarah
    Walter, Vonn
    Weber, Jean-Philip
    Thomas, Roman K.
    Wittersheim, Maike
    Buettner, Reinhard
    Persigehl, Thorsten
    Reinhardt, H. Christian
    SCIENTIFIC REPORTS, 2017, 7
  • [7] Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer
    Fabian Doerr
    Julie George
    Anna Schmitt
    Filippo Beleggia
    Tim Rehkämper
    Sarah Hermann
    Vonn Walter
    Jean-Philip Weber
    Roman K. Thomas
    Maike Wittersheim
    Reinhard Büttner
    Thorsten Persigehl
    H. Christian Reinhardt
    Scientific Reports, 7
  • [8] Treatment of Small Cell Lung Cancer with Lurbinectedin: A Review
    Rajput, Prince Singh
    Khan, Sharib Raza
    Singh, Preeti
    Chawla, Pooja A.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022, 22 (05) : 812 - 820
  • [9] Lurbinectedin in small cell lung cancer
    Manzo, Anna
    Sforza, Vincenzo
    Carillio, Guido
    Palumbo, Giuliano
    Montanino, Agnese
    Sandomenico, Claudia
    Costanzo, Raffaele
    Esposito, Giovanna
    Laudato, Francesca
    Mercadante, Edoardo
    La Manna, Carmine
    Muto, Paolo
    Totaro, Giuseppe
    De Cecio, Rossella
    Picone, Carmine
    Piccirillo, Maria Carmela
    Pascarella, Giacomo
    Normanno, Nicola
    Morabito, Alessandro
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] Combined inhibition of Chk1 and Wee1 kinases for cancer treatment
    Hauge, S.
    Hasvold, G.
    Joel, M.
    Naucke, C.
    Rodland, G. E.
    Syljuasen, R. G.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S478 - S478
12345